A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

COVID-19 vaccine recommendations could be changing ... Prasad wrote in the New England Journal of Medicine that while the development of the vaccines in 2020 marked “a major scientific, medical ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a ...

The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling sales.

Researchers identify SARS-CoV-2`s protective mechanism, offering potential targets for new Covid therapies and vaccine ...

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.